<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02631161</url>
  </required_header>
  <id_info>
    <org_study_id>GHyComp</org_study_id>
    <nct_id>NCT02631161</nct_id>
  </id_info>
  <brief_title>Glass Hybrid Versus Composite Restorations of Non-carious Cervical Lesions</brief_title>
  <official_title>Randomized Controlled Trial on Glass Hybrid Versus Composite Restorations of Non-carious Cervical Lesions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>GC Europe</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A glass hybrid restorative system (EQUIA forte) clinically compared to a composite resin
      based material (Clearfil SE Bond, Filtek Supreme XT) for the treatment of dental non-carious
      cervical lesions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, randomized, monocenter parallel group study on restoration of tooth
      with non-carious cervical restorations. Each patient receives cervical restoration(s) either
      with glass hybrid EQUIA forte or with composite resin/adhesive combination Filtek Supreme
      XT/Clearfil SE Bond in anterior/posterior tooth region. Restorations will be provided by one
      experienced operator. One of two independent examiners will evaluate the restorations at
      baseline (1 week after placement), and after 18, and 36 months according to the FDI criteria.
      Reliability of examination will be assessed on a random sample of 30 restorations.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">December 2015</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Anticipated">February 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of restorations with a re-intervention per all restorations</measure>
    <time_frame>36 months</time_frame>
    <description>Number of all restorations with a re-intervention being required per all placed restorations (events/sample)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Restoration score</measure>
    <time_frame>36 months</time_frame>
    <description>score according to FDI criteria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Costs for initial and retreatment</measure>
    <time_frame>recorded initially and, if required, each re-treatment appointment, over the total trial period (i.e. expected 36 months)</time_frame>
    <description>Costs incurred for staff and material for initial and re-treatments</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">88</enrollment>
  <condition>Dental Cervical Non-carious Lesion</condition>
  <arm_group>
    <arm_group_label>EQUIA forte</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dental non-carious cervical restorations are being restored with a glass hybrid restorative system (Medical product: EQUIA forte).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Filtek Supreme XT/Clearfil SE Bond</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dental non-carious cervical restorations are being restored with a composite resin based material/Adhesive combination (Medical product: Filtek Supreme XT/Clearfil SE Bond).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Equia Forte</intervention_name>
    <description>Restoration of cavities with a Glasshybrid material (Equia Forte)</description>
    <arm_group_label>EQUIA forte</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Filtek Supreme XT/Clearfil SE Bond</intervention_name>
    <description>Restoration of cavities with a composite resin based material after placing an adhesive</description>
    <arm_group_label>Filtek Supreme XT/Clearfil SE Bond</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  indication of a restorative treatment for a sclerotic non-carious cervical lesion

          -  lesions should be accessible for treatment and visual-tactile re-evaluation

          -  sufficient moisture control should be possible

          -  cervical margins should be located in dentin whereas the coronal margin should be
             located in enamel

        Exclusion Criteria:

          -  allergy/hypersensitivity against any of the used materials

          -  participants should not be systematically ill, disabled, pregnant or participating in
             another study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sebastian Paris, Prof. Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Abteilung für Zahnerhaltung und Präventivzahnmedizin, Charité Berlin</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Charité Centrum für Zahn-, Mund- und Kieferheilkunde, Abteilung für Zahnerhaltungskunde und Präventivzahnmedizin</name>
      <address>
        <city>Berlin</city>
        <zip>14197</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 7, 2015</study_first_submitted>
  <study_first_submitted_qc>December 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 16, 2015</study_first_posted>
  <last_update_submitted>May 16, 2018</last_update_submitted>
  <last_update_submitted_qc>May 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Falk Schwendicke</investigator_full_name>
    <investigator_title>PD Dr.</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

